T Riebeling, U Kunzendorf… - Biochemical Society …, 2022 - portlandpress.com
… of these infections poses a major challenge in immunocompromised patients [55,56],
overcoming pathogen persistence would be a substantial therapeutic advantage: the viral RHIM …